Scalable Laboratory Output
Histology Automation & Capacity Planning
Histology automation and new instrumentation create value only when they address the laboratory's real constraint. We help leaders evaluate throughput, labor dependence, variation, IHC headroom, workflow integration, and acquisition models before committing to technology.
Who this service helps
- Histology laboratories facing backlog, variability, or staffing pressure
- Leaders evaluating block facing, embedding, or microtomy automation
- Organizations approaching IHC instrument capacity
- Laboratories comparing purchase, reagent-rental, and partnership options
What the work can accomplish
- A defensible view of current capacity and the constraint limiting output
- Technology requirements grounded in case mix, workflow, and quality needs
- Financial comparison of acquisition and operating models
- An implementation plan that accounts for validation, staffing, and workflow change
How we approach it
- We measure workload, queue patterns, utilization, repeat work, staffing, and the variability affecting output.
- We determine whether the primary constraint is labor, process design, equipment, scheduling, or downstream review.
- We compare automation and instrumentation options using operational fit, quality, economics, and service resilience.
- We plan integration, validation, training, and performance measurement so expected capacity becomes real capacity.
Practical consulting deliverables
- Capacity, utilization, and constraint assessment
- Automation or instrumentation decision criteria
- Labor, quality, and financial impact model
- Validation and implementation roadmap
Engagement scope
Capacity planning can focus on a defined histology process or IHC platform decision, or evaluate the complete bench workflow before a broader automation program.
Experienced pathology leadership
David “DJ” Dalton, PhD, MBA brings more than 20 years of pathology industry experience spanning Labcorp, Paige AI, Lumea/Modella AI, digital pathology, laboratory operations, product strategy, commercialization, and executive leadership.
Last reviewed September 2026. About David Dalton
Frequently asked questions
When should a histology laboratory consider automation?
Automation should be considered when volume, staffing risk, repetitive work, quality variation, or service expectations create a measurable constraint. The business case should compare the technology with workflow and staffing alternatives.
How do we know whether we need another IHC instrument?
Review utilization by time of day, peak demand, downtime risk, test-menu plans, reagent economics, repeats, service expectations, and available backup capacity. Average utilization alone can hide operational risk.
Will automation eliminate histology staffing needs?
Automation changes the work more often than it eliminates it. The value may come from reducing repetitive manual steps, improving consistency, extending capacity, and allowing skilled staff to focus on higher-value activities.